Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab

NCT03306446 is registered in ClinicalTrials.gov with Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives as lead sponsor.

NCT NCT03306446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03306446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab
Lead sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Phase
Phase 4
Overall status
Unknown status
Start date
March 17, 2015
Completion date
March 31, 2025
Enrollment
203 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

cd